TradingView
RocketTickers
Aug 14, 2018 4:50 PM

Motif Bio Announces FDA Acceptance of New Drug Application with  Long

NASDAQ:MTFB1D

Description

⋅
MTFB: Motif Bio plc
2018-08-14 02:00:00
Motif Bio Announces FDA Acceptance of New Drug Application with Priority Review for Iclaprim for Treatment of Acute Bacterial Skin and Skin Structure Infections
Beyond Technical Analysis
More